ASCO 2019 | Treatment-related bone loss

Silke Gillessen

Silke Gillessen, MD, of The Christie NHS Foundation Trust, Manchester, UK, discusses the importance of bone loss in both prostate and breast cancer and how the use of bone-targeted agents can be assessed at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics